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Abstract
Human-specificpseudogenizationof the CMAHgeneeliminated themammalian sialic acid (Sia)Neu5Gc (generatinganexcessof its
precursor Neu5Ac), thus changing ubiquitous cell surface “self-associated molecular patterns” that modulate innate immunity via
engagement of CD33-related-Siglec receptors. The Alu-fusion-mediated loss-of-function of CMAH fixed 2–3 Ma, possibly con-
tributing to the origins of the genus Homo. The mutation likely altered human self-associated molecular patterns, triggering multiple
events, including emergence of human-adapted pathogens with strong preference for Neu5Ac recognition and/or presenting
Neu5Ac-containing molecular mimics of human glycans, which can suppress immune responses via CD33-related-Siglec engage-
ment.Human-specificalterations reported insomegene-encodingSia-sensingproteins suggesteda“hotspot” inhomininevolution.
Theavailabilityofmorehominidgenomes including thoseof twoextincthomininsnowallows full reanalysis andevolutionary timing.
Functional changes occur in 8/13 members of the human genomic cluster encoding CD33-related Siglecs, all predating the human
commonancestor.Comparisonswithgreatapegenomes indicate that thesechangesareuniquetohominins.Wefoundnoevidence
for strongselectionafter theHuman–Neanderthal/Denisovancommonancestor, and theseextincthominingenomes includealmost
all major changes found in humans, indicating that these changes in hominin sialobiology predate the Neanderthal–human diver-
gence0.6Ma.Multiple changes in this genomic clustermayalsoexplainhuman-specificexpressionofCD33rSiglecs inunexpected
locations suchasamnion,placental trophoblast,pancreatic islets,ovarianfibroblasts,microglia,NaturalKiller(NK) cells, andepithelia.
Taken together,ourdata suggest that innate immune interactionswithpathogensmarkedly alteredhomininSiglecbiologybetween
0.6 and 2 Ma, potentially affecting human evolution.
Key words: sialic acid, hominin, evolution, CD33rSiglecs, common ancestor, Neanderthal/Denisovan, great apes, archaic
hominin.
Introduction
Prior to the mid-1990s, the extreme similarity of human and
chimpanzee protein sequences suggested that phenotypic
differences were primarily due to differences in gene regula-
tion (King and Wilson 1975). The first definitive exception was
a fixed loss-of-function genomic mutation unique to the hu-
man lineage, in the gene-encoding CMP-Neu5Ac hydroxylase
(CMAH) (Chou et al. 1998), an event mediated by an Alu–Alu
fusion (Hayakawa et al. 2001). This mutation eliminated bio-
synthesis of the common mammalian sialic acid (Sia)
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N-glycolylneuraminic acid (Neu5Gc) and caused accumulation
of its precursor N-acetylneuraminic acid (Neu5Ac), radically
changing cell surface extracellular glycosylation throughout
the body in the hominin lineage. The mutation was dated
to >2 Ma by multiple methods (Chou et al. 2002;
Hayakawa et al. 2006). Additional examples emerged a few
years later, including the forkhead box protein P2 (FOXP2)
(Enard et al. 2002, 2009), a myosin heavy chain family mem-
ber (MHY16) (Currie 2004; Stedman et al. 2004), and exam-
ples of gene duplication followed by adaptive evolution
(Johnson et al. 2001). Along with biomedical considerations
(Varki 2000), such discoveries lead to sequencing of the chim-
panzee genome (Chimpanzee Sequencing and Analysis
Consortium 2005). There are now many more defined ge-
netic differences between humans and our closest evolution-
ary cousins, involving not only gene expression (Enard et al.
2002; Fujiyama et al. 2002; Watanabe et al. 2004; Calarco
et al. 2007; Kehrer-Sawatzki and Cooper 2007; Cruz-Gordillo
et al. 2010; Otto et al. 2014; Atkinson et al. 2018) but also
other distinct genomic changes ranging from massive (mega-
base) structural variation to differences in gene copy numbers,
de novo genes, pseudogenization (O’Bleness et al. 2012; Ruiz-
Orera et al. 2015), human-accelerated regions in noncoding
regions, and microRNA genes (Eddy 2001; Mello and Conte
2004; Kim 2005; Ruiz-Orera et al. 2015).
This study focuses on human genes involved in the biology
of sialic acids. All living cells are covered with complex arrays
of glycoconjugates, with sialic acids occupying the majority of
terminal positions on such glycan chains in animals of the
Deuterostome lineage (including echinoderms and verte-
brates) (Gagneux et al. 2015). These acidic, nine-carbon
backbone amino-sugars play important roles in cell–cell and
cell–matrix interactions, as well as in host–pathogen interac-
tions (Varki et al. 2015). The hominin-specific loss-of-function
mutation in CMAH mentioned above eliminated biosynthesis
of Neu5Gc, which was a target for selective cell recognition by
various nonhuman pathogens and toxins (Kyogashima et al.
1989; Martin et al. 2005; Campanero-Rhodes et al. 2007;
Deng et al. 2014; Alisson-Silva et al. 2018). It is reasonable
to speculate that exogenous pathogen recognition could have
initially driven the CMAH loss-of-function, generating a poly-
morphism as the recessive loss-of-function mutant allele rose
in frequency. However, this deletion was then fixed in an
ancestral hominin population 2–3 Ma (Chou et al. 2002),
possibly by directional selection against Neu5Gc via female
immunity during reproduction, a mechanism demonstrated
in vivo using transgenic mice that carry the same mutation
in their Cmah gene as humans (Ghaderi et al. 2011). Given
the likely timing of these events, we speculated that anti-
Neu5Gc immunity of hominin females immunized against
Neu5Gc by increased contact with Neu5Gc-rich vertebrate
animal prey might have contributed to the origins of the ge-
nus Homo 2 Ma (Wood and Boyle 2016; Bergfeld et al.
2017).
Early discovery of some additional human-specific changes
affecting sialic acid biology (Brinkman-Van der Linden et al.
2000; Angata, Varki, et al. 2001; Gagneux et al. 2003;
Sonnenburg et al. 2004; Hayakawa et al. 2005; Nguyen
et al. 2006) and system-wide genomic and biochemical com-
parisons of sialic acid biology among primates and rodents
(Altheide et al. 2006) suggested a possible “hotspot” in hu-
man sialic acid evolution (Varki 2009). With the availability of
more human genomes (1000 Genomes Project Consortium
et al. 2015), a recent study showed the patterns of genetic
variation of 55 sialic acid biology-related genes in modern
human populations did not significantly deviate from neutral
expectations and were in fact not significantly different
among genes belonging to different functional categories
(Moon et al. 2018).
Sialic acid binding Ig-like lectin (Siglecs) are type I trans-
membrane proteins with an N-terminal immunoglobulin
(Ig)-like-V-set domain that mediates sialic acid recognition,
and a variable number of Ig-like-C-2 type domains (Angata,
Hingorani, et al. 2001). Siglecs often have a cytoplasmic tail
with one or more immunoreceptor tyrosine-based inhibitory
motifs that can suppress immune cell activation. Alternatively,
they can recruit adaptor proteins with immunoreceptor
tyrosine-based activating motifs. Although Siglecs likely have
multiple functions, one prominent role appears to be recog-
nition of endogenous sialylated glycans as self-associated mo-
lecular patterns, suppressing reactions of innate immune cells
against self (Varki 2011). Activating Siglecs have a positively
charged arginine or lysine in their transmembrane domains
that can recruit DAP12 and activate cellular immune
responses against pathogens mimicking endogenous sialic
acids (Schwarz et al. 2017). CD33-related Siglecs are rapidly
evolving and among this family, nine inhibitory (hSiglec-3 and
hSiglec-5 to hSiglec-12) and two activating members (hSiglec-
14 and hSiglec-16) have been characterized in humans.
Recently, an article published from our group showed variable
presence or absence of functional changes in the
CD33rSIGLEC cluster in 26 mammalian species including great
apes (Khan et al. 2020).
With the availability of genomes from both living great
apes (Prado-Martinez et al. 2013; Xue et al. 2015;
Kronenberg et al. 2018) and extinct archaic hominins (Reich
et al. 2010; Meyer et al. 2012; Prufer et al. 2014), we now
systematically reassess the previous discoveries from multiple
groups and also report on several new findings. Overall, we
find that multiple complex changes in genes involving sialic
acid biology beyond the initial CMAH mutation did indeed
occur but are mostly confined to the CD33rSIGLEC gene clus-
ter on chromosome 19 (Angata, Hingorani, et al. 2001),
encoding CD33rSiglecs, prominent on innate immune cells
(Varki and Angata 2006).
Overall, we found that multiple changes in the
CD33rSIGLEC gene cluster are common in all human popula-
tions, postdate the common ancestor with the chimpanzee/
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bonobo lineage, but predate the common ancestor with
Neanderthals and Denisovans. Such multiple complex
changes in this gene cluster appear to be associated with
altered expression of these genes, not just confined to innate
immune cells, but also in other unexpected human cell types,
some associated with diseases that appear to be uniquely
human.
Materials and Methods
Genome Assembly and Identification of Variants across
Humans and Great Apes
The great ape genome data (total number 147) for CMAH
and CD33rSIGLECs were derived from three publications
(Prado-Martinez et al. 2013; Xue et al. 2015; de Manuel
et al. 2016; Kronenberg et al. 2018). These great ape
genomes were mapped to human reference genome
(GRCh37/hg19) retrieved from UCSC genome browser, using
Burrows–Wheeler aligner and further processed with Picard
tool to remove duplicates and variant were called using
Genome-analysis toolkit. Moreover, the variants in variant
call format of chimpanzee, bonobos, gorilla, and orangutan
were visualized in integrative genome viewer with their re-
spective reference genome (Pantro4, Gorgor3, and PonAbe2)
and annotation file. All archaic hominins raw and processed
files were obtained from the Max Planck Institute for
Evolutionary Anthropology (Reich et al. 2010; Castellano
et al. 2014; Prufer et al. 2014; Slon et al. 2018) (http://cdna.
eva.mpg.de/neandertal). Bed coordinates of SIGLECs and
CMAH genes were provided for each human and ape lineage
as supplemental (chimpanzee, gorilla, and orangutan) (sup-
plementary file 1, Supplementary Material online).
Additionally, bed coordinates of additional polymorphism pre-
sent in CD33rSIGLECs with allele frequency in great ape pop-
ulation were also provided as supplemental (supplementary
file 2, Supplementary Material online).
Inference of Strong Archaic Natural Selection
The genes involved in sialic acid biology (67 genes) were over-
lapped with regions displaying signatures of ancient selective
sweeps (Peyregne et al. 2017). The method used to identify
these signatures of archaic selection relies on a hidden
Markov model to detect extended regions in the genome
where the Neanderthal and Denisovan lineages fall outside
the human variation (Meyer et al. 2012; Prufer et al. 2014).
This method can only detect events that occurred between
the split of modern and archaic humans around 0.5 Ma
(Prufer et al. 2017) and the split of modern human popula-
tions from each other around 0.2 Ma (Schiffels and Durbin
2014). For events with a selective advantage of 0.5% or
larger, with an origin of the beneficial mutation as old as
600,000 years ago, the false positive rate of the method is
lower than 0.1% and its true positive rate is larger than 65%
(Peyregne et al. 2017). We also note that signals of positive
selection are not detectable if the selection coefficient is
smaller than 0.1%. The Ensembl database (release 82)
(Aken et al. 2016) was used to annotate each gene with
hg19 coordinates from transcription start to transcription
end. Furthermore, L1CAM, PECAM, CMAH, SIGLEC13,
SIGLEC16, and SIGLEC17 were excluded because they fall ei-
ther in filtered regions not considered for the ancient sweep
screen or could not be mapped to hg19 coordinates. As reg-
ulatory regions may also have been the target of positive se-
lection, we extended the start and end coordinates 1 Mb
upstream and downstream, respectively. If a neighboring
gene was within 1 Mb, we only extended the coordinates
until 5 or 1 kb from the transcription start or end of this
neighboring gene. In order to test whether the lack of signa-
tures of ancient selection is statistically significant, the candi-
date regions of ancient selection were randomly placed in the
genome and the random placements of all regions were iter-
ated 1,000 times, counting how often no overlap with genes
involved in sialic acid biology was detected. The depletion in
selection is not significant (356 sets never overlap; P value ¼
0.356).
Immunohistochemistry of Siglecs
Paraffin sections were deparaffinized in xylene and rehy-
drated in decreasing concentrations of ethanol and Tris-
buffered saline–Tween (TBST). Following this, endogenous
binding sites and peroxidases were blocked with 1% bovine
serum albumin/TBST and 0.3% H2O2/TBST. This was followed
by blocking of endogenous biotin and then heat-induced an-
tigen retrieval was performed in citrate buffer pH 6. Primary
antibodies (mouse anti-Siglec-7 and Rabbit anti-Siglec-13) or
mouse IgG were then overlaid at optimal dilutions, and slides
were incubated overnight at 4 C in a humid chamber.
Specific binding was detected using a biotinylated anti-
mouse or anti-rabbit (for Siglec-13), followed by Horseradish
Peroxidase (HRP) streptavidin and then biotinyl tyramide en-
hancement and then HRP streptavidin. Substrate color was
developed, and nuclei were counterstained with hematoxylin
and the slides were aqueous mounted for viewing and digital
photomicrography using an Olympus BH2 microscope with
an Olympus magnafire camera.
Results
Multiple Derived, Fixed, or Polymorphic Genomic SIGLEC
Variants Are Present in All Modern Human Populations
Table 1 summarizes events and frequencies in human popu-
lations based on the 1000 Genomes Project data and com-
pares these with archaic hominin and great ape genomes. All
human genomic changes in CD33-related SIGLECs (affecting
8 out of 13 members of this class of genes) were present
across modern human populations. Genome-wide
Khan et al. GBE
1042 Genome Biol. Evol. 12(7):1040–1050 doi:10.1093/gbe/evaa125 Advance Access publication 18 June 2020
association studies identified a derived CD33-linked allele
(rs3865444(A), rs12459419(T)) that is protective against late
onset Alzheimer’s disease (Schwarz et al. 2016). The linked
single-nucleotide polymorphism was found to be variable
across human populations with highest frequency in native
American populations (48%) and lowest in African popula-
tions (5%). The previously reported Alu-mediated human
SIGLEC13 deletion (Wang, Mitra, Secundino, et al. 2012)
and SIGLEC17 (Siglec-P3) pseudogenization due to Open
reading frame disruption and mutation of a critical arginine
residue in its V-set domain (Wang, Mitra, Secundino, et al.
2012) appear to be fixed in all humans. SIGLEC12, SIGLEC14,
and SIGLEC16 show polymorphic pseudogenization in vari-
able frequencies across human populations, as detailed in ta-
ble 1. SIGLEC12 also harbors a human-universal mutation of
the critical arginine residues in the V-set domain (Arg -> Cys,
first V-set domain) abrogating its ability to recognize sialic
acid. An additional SIGLEC12 inactivation mutation
(rs16982743) was found at an overall 18.6% frequency, high-
est in Africans (37%) and lowest in East Asians (5%). Another
SIGLEC12 polymorphism, that is, frameshift (rs66949844)
averages 59% (highest in native Americans and lowest in
East Asians) in human population. Additionally, based on
the two linked alleles present in SIGLEC16 (rs12611411(T)
and rs12984584(C)), the pseudogene variant (SIGLEC16P) is
present in higher frequency than the functional allele
(SIGLEC16) in human populations (Wang, Mitra, Cruz, et al.
2012). Because these SIGLEC clusters are undergoing multiple
gene conversions, some regions are highly prone to low map-
ping quality and hence some variants are not well defined, for
example, SIGLEC14 fusion-deletion, which is highly prevalent
in East Asian populations (Yamanaka et al. 2009; Ali et al.
2014). Due to the lack of high coverage sequence data, these
regions have not been well genotyped in nonhuman
genomes. The CMAH exon deletion is confirmed to be uni-
versal to humans.
Great Ape Genomes Do Not Show a High Frequency of
SIGLEC Gene Mutations
Our previous human–ape comparisons involved the incom-
plete draft of a single chimpanzee genome, a few additional
incomplete great ape sequences and a small number of hu-
man genomes (Chimpanzee Sequencing and Analysis
Consortium 2005). Thus, it remained possible that the geno-
mic changes were actually a common feature of such genes
across all these taxa. The availability of newly annotated ver-
sions of great ape genomes (Prado-Martinez et al. 2013; Xue
et al. 2015; de Manuel et al. 2016; Kronenberg et al. 2018)
now allows for much better control against ascertainment
bias, by comparing human-specific polymorphisms with mul-
tiple different genomes for each ape species, capturing po-
tential polymorphisms in the latter as well (Sullivan et al.
2017). We observed that great ape genomes share none ofTa
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the mutations observed in human populations. Instead, we
only observed independent changes in critical arginine resi-
dues in V-set domain of SIGLEC5/14, rendering them unable
to recognize sialic acids (table 1). Although the essential argi-
nine change (Arg -> His) in SIGLEC5 was found to be poly-
morphic in chimpanzee and gorilla, sequences in orangutan
were not recognized due to low mappability. The SIGLEC14
essential arginine change (Arg -> His) was found to be poly-
morphic in chimpanzee, bonobo, and gorilla. However,
sequences of SIGLEC14 in orangutan were not determined
in most of the species due to low coverage, except for
one that harbors an essential arginine change to tyrosine
(Arg -> Tyr). The CMAH gene is functional in all great apes
as expected, given that both types of sialic acids (Neu5Ac and
Neu5Gc) are present in all these species (Muchmore et al.
1998). Overall, human genomes harbored a far greater num-
ber of structural/functional changes in CD33rSIGLEC genes
(see fig. 1 and supplementary file 2, Supplementary
Material online).
Most Human Lineage-Specific Mutations Are Also Found
in Archaic Hominin Genomes
To further understand the timing of these human genomic
changes of these human genomic variants, we looked for
their presence in archaic human genomes, that is,
FIG. 1—Evolutionary changes in hominid SIGLEC genes. The tree represents phylogenetic relatedness among hominids and different types of
genomic events are depicted according to the color codes. Siglec expression differences are based on more limited comparisons (see table 1 and fig. 3
and see text for discussion).
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Neanderthal and Denisovan. The exon deletion leading to
loss-of-function of the CMAH gene is shared by these two
archaic genomes, as expected based on the existing estimates
of fixation of the mutation over 2 Ma (Hayakawa et al. 2001).
Notably, almost all other human CD33rSIGLECs variants (ex-
cept for CD33-linked variants protective against late onset
Alzheimer’s disease) were also present in these archaic hom-
inin genomes in variable frequency (listed in table 1 and fig. 1)
placing their origin before the human–Neanderthal common
ancestor (0.6 Ma) (Prufer et al. 2017; Hajdinjak et al. 2018).
Due to unavailability of well annotated sequences, the
SIGLEC14 fusion/deletion could not be determined in archaic
hominins.
Lack of Evidence for Strong Selection up to 500,000 Years
Ago
The presence of all genomic SIGLEC changes in human pop-
ulations indicates that they predate the common ancestor of
modern humans 0.2–0.3 Ma (Hublin et al. 2017).
Consistent with this observation, the recent article by Moon
et al. (2018) found that the patterns of genetic variation of
most CD33rSIGLEC genes did not significantly deviate from
neutral expectations, and the few that did significantly deviate
from neutrality experienced either soft sweeps or population-
specific hard sweeps (Moon et al. 2018). Using a method that
allows detection of selection in deeper time (0.5 Ma)
(Peyregne et al. 2017), we also found no evidence of strong
selection after the ancestors of modern and archaic humans
(Neanderthal–Denisovan) split from each other around
500,000 years ago. As selection may also target neighboring
regulatory regions, we defined regulatory domains around
each gene and looked for overlaps with candidate sweep
regions. Using these extended gene coordinates, we again
found no overlap with candidate regions for selective sweeps,
suggesting that none of the genes involved in sialic acid biol-
ogy exhibits strong signatures of selection more recently than
0.5 Myr in the common ancestral population of all modern
humans. The description of extended lineage sorting (ELS) is
provided in figure 2.
Human-Specific Expression of CD33rSiglecs in
Nonimmune Tissues
In addition to these multiple, polymorphic complex genomic
changes in the human CD33rSIGLEC gene cluster, there ap-
pear to be unusual (derived) human-specific expression pat-
terns of CD33rSiglecs (in nonhemopoietic cells) in locations
such as placental trophoblast (SIGLEC6) (Kang et al. 2011),
ovarian fibroblasts (SIGLEC11/16) (Wang et al. 2011), amni-
otic epithelium (SIGLEC5/14) (Ali et al. 2014), and microglia
(SIGLEC11/16) (Hayakawa et al. 2005). In each of the above
instances, we have previously reported human-specific ex-
pression and lack of expression in chimpanzee tissue samples
(in some instances also other available great ape tissues). With
regard to the recent report of SIGLEC7 expression in human
pancreatic islets (Yamaguchi et al. 2017), we now show that
such expression is missing in chimpanzee pancreatic islets
FIG. 2—Description of the ELS scan. (A) Illustration of the selection signature. Patterns of shared mutations (dots) were used to reconstruct the genealogy
that relate an archaic human Altai Neanderthal (Prufer et al. 2014); or Denisovan (Meyer et al. 2012); top rectangle to modern humans (bottom rectangles) at
any given position along their genomes. There are two types of genealogies: the archaic falls either outside the modern human variation (external genealogy)
or inside (internal genealogy). The internal genealogy is the most frequent in the genome. However, if a mutation spread among the ancestors of modern
humans (blue dot) more recently than the population split with the ancestors of archaic humans, the archaic will be expected to fall outside the modern
human variation in the genomic region around the mutation that has not been unlinked by recombination (blue rectangles). This region is expected to be
large if the mutation was positively selected and spread quickly in the population, not leaving enough time for recombination to break its linkage with other
mutations (black dots). (B) Time scales for the signatures of selection in humans. The tree represents the simplified population history of Neanderthals,
Denisovans, and modern humans (Prufer et al. 2017). The colors indicate the time scales investigated by the ELS scan (red) and other methods (blue) used to
detect events of positive selection on the modern human lineage.
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(fig. 3). We also found that Siglec-13, which is deleted in
hominins, is highly expressed in chimpanzee intestinal epithe-
lium and skin (fig. 3). Current and previously published data
are summarized in table 2. Although we obviously cannot
detect tissue-specific expression in Neanderthals or
Denisovans, it is reasonable to consider the possibility that
these unusual human-specific expression patterns arose dur-
ing the course of the large-scale changes affecting the
CD33rSIGLECs gene cluster during the proposed “hotspot”
and would thus have already existed in both of those extinct
relatives.
Discussion
Recent availability of sequences of many modern human
genomes (1000 Genomes Project Consortium et al. 2015), ar-
chaic hominins (Green et al. 2010; Reich et al. 2010, 2011;
Meyer et al. 2012, 2016; Castellano et al. 2014; Prufer et al.
2014, 2017; Sawyer et al. 2015; Kuhlwilm et al. 2016; Slon
et al. 2018), and great apes (Prado-Martinez et al. 2013; Xue
et al. 2015; de Manuel et al. 2016) provides a tool for under-
standing the role of evolution in shaping genetic architecture
andallowingus to identify thegeneticbasisofphenotypic traits
of various species (Haffter et al. 1996; Bryk and Tautz 2014;
Valenzano et al. 2015; Castellano and Munch 2020). Our ear-
lier studiesnotedmultiplegenomicchangesaffectingsialic acid
biology, and we suggested the possibility of a hotspot in
humans affecting these pathways compared with our closest
evolutionary relatives (Altheide et al. 2006). However, the lim-
ited availability of annotated and high coverage genomes at
the time left the question unresolved, and our suggestion has
been recently tested by others (Moon et al. 2018), who could
not find evidence for strong selective sweeps in current human
populations. We herewith show that apart from the fixed
CMAH null mutation and increased expression of ST6GAL1
(Gagneux et al. 2003), most of the human-specific changes
affecting sialic acid biology are found in the SIGLEC gene clus-
ter on chromosome 19, and that although great ape genomes
donot showmanychanges in this cluster, almost all thehuman
changes are also found in archaic genomes of Neanderthals
and Denisovans (Reich et al. 2010; Castellano et al. 2014;
Prufer et al. 2014; Slon et al. 2018; Bokelmann et al. 2019).
In keeping with this overall conclusion, there was no evidence
for strong selectivepressure in this cluster after0.6Ma, when
the human lineage diverged from Neanderthal–Denisovan
common ancestor.
With regard to timing and order of changes, the most likely
possibility is that the CMAH mutation first dramatically altered
sialic acids throughout the body, possibly initiating a series of
events that resulted in SIGLEC cluster changes. The complex
and dynamic relationships between host and pathogens is
often characterized by the Red Queen hypothesis, whereby
slowly evolving hosts have to keep changing to keep pace
with the pressure exerted by more rapidly evolving pathogens.
Sialic acids form one primary interface, “the molecular fron-
tier” in this evolutionary arms race. The loss-of-function of
CMAH and the changes in ST6GAL1 expression undoubtedly
led to multiple alterations of human–pathogen interactions.
The direct consequence was the change in human cell surfa-
ces, leading to overexpression of Neu5Ac, escaping Neu5Gc-
specific pathogens, and favoring human pathogens that in-
teract with Neu5Ac. There are many other known and possi-
ble biological consequences of human Neu5Gc loss (Varki
2009; Okerblom and Varki 2017), including protection from
various Neu5Gc-recognizing pathogens such as malaria
caused by Plasmodium reichenowi in African great apes
(Martin et al. 2005), Escherichia coli K99 gastroenteritis
(Kyogashima et al. 1989), transmissible gastroenteritis coro-
navirus (Schwegmann-Wessels and Herrler 2006), and simian
virus 40 (Campanero-Rhodes et al. 2007). Conversely, CMAH
loss likely made humans susceptible to Neu5Ac-preferring
pathogens such as Vibrio cholerae (causative agent of the
human-specific disease cholera) (Alisson-Silva et al. 2018)
and typhoid fever caused by a secreted bacterial toxin that
FIG. 3—Examples of immunohistochemistry using antibodies against Siglec-7 and Siglec-13 on human and chimpanzee tissues (see Materials
and Methods for detail). (A) No difference in expression of Siglec-7 in splenic blood cells. There is markedly increased expression of Siglec-7 in
human pancreatic islets. (B) Siglec-13 expression in chimpanzee skin and prostatic epithelium. The gene-encoding Siglec-13 is completely deleted in
humans. Scale bars ¼ 100 lm.
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preferentially recognizes Neu5Ac (Deng et al. 2014). Another
human-specific pathogen Streptococcus pneumoniae recog-
nizes free Neu5Ac released from human cells by its secreted
sialidase (Hentrich et al. 2016). Yet another secondary conse-
quence appears to have been the evolution of pathogens that
express Neu5Ac on their surfaces as a way to engage CD33-
related Siglecs and downregulate innate immune responses in
the human host. Again, the existence of many human-specific
pathogens that display Neu5Ac supports this scenario
(Angata 2018). For example, Group B Streptococcus type III,
interacts with Siglec-9 through sialylated CPS and inhibits in-
flammatory response by neutrophils (Carlin et al. 2009).
Likewise, nontypeable Haemophilus influenzae expressing si-
alic acid on its lipooligosaccharide binds to Siglec-5 and
reduces cytokine production by myeloid cells (Angata et al.
2013), and the E. coli K1 strain that causes meningitis in neo-
nates and infection in urinary tract, engages Siglec-11, and
escapes killing (Hayakawa et al. 2017). Also, as expected,
nonhuman primate Siglec-9 prefers binding to Neu5Gc,
whereas human Siglec-9 prefers binding to Neu5Ac
(Sonnenburg et al. 2004). Likewise, human Siglec-5 and
CD33 prefer binding to Neu5Ac, compared with the baboon
CD33, which strongly prefers Neu5Gc (Padler-Karavani et al.
2014). These findings imply that Siglecs underwent adapta-
tion in new environments to “catch up” with the changes in
human sialome caused by the hominin CMAH mutation.
Some human Siglecs still prefer binding to Neu5Gc (Angata
2018), perhaps due to incomplete adaptation to the derived,
human Neu5Ac-dominant sialome.
Although these genomic changes are ancient, evidence
also suggests that existing human polymorphisms are associ-
ated with several diseases such as Chronic obstructive pulmo-
nary disease, asthma, Alzheimer’s disease, and meningitis
(Yamanaka et al. 2009; Gao et al. 2010; Ali et al. 2014;
Schwarz et al. 2016). In addition, human Siglec-XII and chim-
panzee Siglec12 are expressed on macrophages and luminal
epithelia (Mitra et al. 2011). However, human Siglec-XII har-
bors a universal mutation (R122C) that makes the protein
unable to recognize sialic acid. Interestingly, chimpanzee
Siglec12 and human Siglec-XII with its arginine experimentally
restored strongly prefer Neu5Gc (Mitra et al. 2011). These
results suggest a scenario where Siglec-12 lost an endoge-
nous ligand and is thus being eliminated from the population.
Prior studies have reported human-specific Siglec expres-
sion changes in placenta (Siglec-6) (Brinkman-Van der Linden
et al. 2007), brain microglia (CD33/Siglec11/16) (Hayakawa
et al. 2005; Schwarz et al. 2016), amniotic epithelium (Siglec-
5/14) (Ali et al. 2014), ovarian fibroblasts (Siglec11/16) (Wang
et al. 2011), and NK cells (Siglec-17) (Wang, Mitra, Secundino,
et al. 2012). We here add to these expression differences by
showing that Siglec-7 is upregulated in human but not chim-
panzee pancreatic islets, and that the SIGLEC13 deletion
resulted in a loss of Siglec-13 expression from human epithe-
lia. Many of these expression changes could represent
secondary consequences of multiple genomic changes that
occurred in this gene cluster earlier in the hominin lineage.
Overall, it is likely that the selective pressures driving all these
changes were most prominent sometime after the split from
the common ancestor of human and chimpanzee, but before
the split from the Human–Neanderthal–Denisovan common
ancestor.
Taken together, our data suggest that innate immune
encounters with pathogens markedly altered hominin Siglec
biology between 0.6 and 2 Ma, potentially affecting human
evolution. Notably, this is the time period when a variety of
changes were occurring in genus Homo, including exploration
of new habitats (White et al. 1993; Semaw et al. 1997;
deMenocal 2011), striding bipedalism and running (Bramble
and Lieberman 2004; Lieberman 2015), and scavenging and
hunting, involving butchery of animal carcasses with stone
tools (Semaw et al. 1997; O’Connell et al. 2002; McPherron
et al. 2010; Sayers and Lovejoy 2014; Harmand et al. 2015;
Baird et al. 2016), activities that may have increased risk of
injury, novel infections, and use of fire (Smith et al. 2015). In
this regard, it is also interesting that human-like elimination of
Cmah in mice enhances running ability (Okerblom et al. 2018)
as well as macrophage activation (Okerblom et al. 2017).
Supplementary Material
Supplementary data are available at Genome Biology and
Evolution online.
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